LIVIVO - Search results -

Search results

Result 1 - 10 of total 146

Search options

Article: Cardiac Manifestations Of Coronavirus (COVID-19)

Basu-Ray, Indranill / Soos, Michael P.

StatPearls

Abstract: Coronaviruses are a large family of single positive-stranded, enveloped RNA viruses that can infect ... many animal species and humans Human coronaviruses can be divided based on their pathogenicity The types with high ...

Abstract	Coronaviruses are a large family of single positive-stranded, enveloped RNA viruses that can infect many animal species and humans Human coronaviruses can be divided based on their pathogenicity The types with high pathogenicity including SARS-CoV, MERS-CoV, and current novel SARS-CoV2 [1] Cross-species transmission is the most likely model of the initial transmission from bat to human The initial transfer believed to have happened in Wuhan, China [2][3]
Keywords	covid19
Publisher	WHO
Document type	Article
Note	WHO #Covidence: #94989
Database	COVID19

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾

Article: Cardiac Manifestations of Coronavirus Disease 2019 (COVID-19): A Comprehensive Review.

Tahir, Faryal / Bin Arif, Taha / Ahmed, Jawad / Malik, Farheen / Khalid, Muhammad

Cureus

2020 Volume 12, Issue 5, Page(s) e8021

Abstract: ... has become a pandemic and spread to 209 countries. As coronavirus disease 2019 (COVID-19) is a very ... as well. Cardiac involvement in COVID-19 seems to be a result of an inflammatory storm in response ... to oxidative stress, may account for acute cardiac injury in COVID-19. Nevertheless, the mechanism of heart injury ...

Abstract	Since its origin in China, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has become a pandemic and spread to 209 countries. As coronavirus disease 2019 (COVID-19) is a very rapidly emerging disease, organ-specific studies related to it have been reported. Apart from respiratory findings, some studies have highlighted inflammatory consequences in the heart, kidney, and/or liver as well. Cardiac involvement in COVID-19 seems to be a result of an inflammatory storm in response to the infection. Moreover, direct viral invasion of cardiomyocytes, as well as a myocardial injury due to oxidative stress, may account for acute cardiac injury in COVID-19. Nevertheless, the mechanism of heart injury in COVID-19 is not clear yet. However, multiple studies that highlight the clinical features, laboratory findings, and prognosis of acute myocardial injury (AMI) in COVID-19-affected individuals have been published. In this review, we have summarized the findings of all those studies as well as the clinical features and management of cardiac injury discussed by some case reports.
Keywords	covid19
Language	English
Publishing date	2020-05-08
Publishing country	United States
Document type	Journal Article ; Review
ZDB-ID	2747273-5
ISSN	2168-8184
ISSN	2168-8184
DOI	10.7759/cureus.8021
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Article ; Online: Cardiac Manifestations of Coronavirus Disease 2019 (COVID-19): a Multicenter Cohort Study.

Kim, Minkwan / Nam, Jong Ho / Son, Jang Won / Kim, Sun Oh / Son, Nak Hoon / Ahn, Chul Min / Shim, Chi Young / Hong, Geu Ru / Kim, In Cheol / Choi, Jinwoo / Kang, Seung Mo / Choi, Yeoung Ho / Yoon, Hae Kyoung / Uhm, Jae Sun / Jung, In Hyun

Journal of Korean medical science

2020 Volume 35, Issue 40, Page(s) e366

Abstract: Background: This study aimed to investigate the cardiac manifestations of coronavirus disease 2019 ... COVID-19).: Methods: From February to March 2020, we prospectively and retrospectively enrolled ... consecutive patients diagnosed with COVID-19. Patient's data such as the demographic characteristics, symptoms ...

Abstract	Background: This study aimed to investigate the cardiac manifestations of coronavirus disease 2019 (COVID-19). Methods: From February to March 2020, we prospectively and retrospectively enrolled consecutive patients diagnosed with COVID-19. Patient's data such as the demographic characteristics, symptoms, vital signs, laboratory and radiologic findings, electrocardiographic, and echocardiographic data, including the global longitudinal strain (GLS) of both ventricles, were obtained. Results: Forty patients (median age, 58 years; 50% men) were enrolled in the initial analysis. Patients were classified into severe and nonsevere groups based on the current guidelines. The 13 patients in the severe group were significantly older, had a greater prevalence of bilateral pneumonia and leukocytosis, and higher aspartate transaminase levels than patients in the nonsevere group. Patients in the severe group had a slightly lower left ventricular ejection fraction (LVEF) than those in the nonsevere group (median [interquartile range], 61.0% [58.5%, 62.3%] vs. 66.7% [60.6%, 69.8%], Conclusion: Patients with severe COVID-19 had lower LVEF and LVGLS. RVGLS was not different between patients with severe and nonsevere COVID-19.
MeSH term(s)	Adult ; Aged ; Betacoronavirus ; COVID-19 ; COVID-19 Testing ; Clinical Laboratory Techniques ; Coronavirus Infections/complications ; Coronavirus Infections/diagnosis ; Echocardiography ; Electrocardiography ; Female ; Heart/physiopathology ; Heart Diseases/diagnosis ; Heart Diseases/virology ; Heart Ventricles ; Hospitalization ; Humans ; Male ; Middle Aged ; Observer Variation ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/diagnosis ; Prospective Studies ; Reproducibility of Results ; Retrospective Studies ; SARS-CoV-2 ; Ventricular Dysfunction, Left/diagnosis ; Ventricular Dysfunction, Left/virology ; Ventricular Function, Left
Keywords	covid19
Language	English
Publishing date	2020-10-19
Publishing country	Korea (South)
Document type	Journal Article ; Multicenter Study
ZDB-ID	639262-3
ISSN	1598-6357 ; 1011-8934
ISSN (online)	1598-6357
ISSN	1011-8934
DOI	10.3346/jkms.2020.35.e366
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.B 3163: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Cardiac Manifestations of Coronavirus Disease 2019 (COVID-19): A Comprehensive Review

Tahir, F. / Bin Arif, T. / Ahmed, J. / Malik, F. / Khalid, M.

Cureus

Abstract: ... has become a pandemic and spread to 209 countries As coronavirus disease 2019 (COVID-19) is a very ... as well Cardiac involvement in COVID-19 seems to be a result of an inflammatory storm in response ... to oxidative stress, may account for acute cardiac injury in COVID-19 Nevertheless, the mechanism of heart injury ...

Abstract	Since its origin in China, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has become a pandemic and spread to 209 countries As coronavirus disease 2019 (COVID-19) is a very rapidly emerging disease, organ-specific studies related to it have been reported Apart from respiratory findings, some studies have highlighted inflammatory consequences in the heart, kidney, and/or liver as well Cardiac involvement in COVID-19 seems to be a result of an inflammatory storm in response to the infection Moreover, direct viral invasion of cardiomyocytes, as well as a myocardial injury due to oxidative stress, may account for acute cardiac injury in COVID-19 Nevertheless, the mechanism of heart injury in COVID-19 is not clear yet However, multiple studies that highlight the clinical features, laboratory findings, and prognosis of acute myocardial injury (AMI) in COVID-19-affected individuals have been published In this review, we have summarized the findings of all those studies as well as the clinical features and management of cardiac injury discussed by some case reports
Keywords	covid19
Publisher	WHO
Document type	Article
Note	WHO #Covidence: #596956
Database	COVID19

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾

Article ; Online: Clinical cardiac manifestations in patients with coronavirus disease 2019 (COVID-19)

Hafizha Herman / Putrika PR Gharini / Lucia Kris Dinarti

Journal of the Medical Sciences, Vol 52, Iss

2020 Volume 3

Abstract: The pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome ... heart failure and diabetes mellitus. Early recognition of cardiac manifestations from COVID-19 infections ... against myocardial inflammation and lung injuries. Several cases of COVID-19 infection may have cardiac ...

Abstract	The pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 2 million people worldwide with case fatality rates between 3-15%. The pathophysiology of this newly emerging disease in affecting cardiovascular system is poorly understood. This review aimed to understand from various retrospective studies and case reports that have been published and updated during the pandemic of COVID-19 related to the underlying mechanism and cardiovascular interaction with coronavirus. A literature search was done with Google search, PubMed, European Society of Cardiology (ESC) and Journal of American Medical Association (JAMA) network since the early days of COVID-19 pandemic. Clinical presentation may be asymptomatic or the severe cases will have acute respiratory distress syndrome (ARDS). Protein spikes of SARS-CoV-2 virus use the angiotensin-converting enzyme 2 (ACE2) as viral entry to host cells. Due to the upregulation of ACE2, people with any pre-existing cardiac diseases are more vulnerable to the infection and more likely to have a severe condition of COVID-19 infection with a higher risk of mortality. On the other hand, ACE2 has protective effects against myocardial inflammation and lung injuries. Several cases of COVID-19 infection may have cardiac manifestations as a chief complaint or acute cardiac injury as the complication. Recent case reports show that acute cardiac injury, myocarditis, cardiogenic shock, thromboembolism, and arrhythmias could be the complications of COVID-19 even without history or risk factors of cardiovascular disease. There are several hypotheses related to the mechanism of acute cardiac injury in COVID-19 patients, including damage through ACE2 receptors, hypoxia, cardiac microvascular damage, and inflammatory response.COVID-19 infection can cause many interactions in the cardiovascular system, whether the patients already had chronic heart disease or not. Considering the lack of evidence of the RAS inhibitor in COVID-19, the use of ACE inhibitor/ARB should be continued unless contraindicated and may be beneficial in patients with hypertension, heart failure and diabetes mellitus. Early recognition of cardiac manifestations from COVID-19 infections will be the key to prevent short and long term cardiac adverse events.
Keywords	ace inhibitor ; acute cardiac injury ; cardiogenic shock ; coronavirus ; myocarditis ; Medicine ; R ; covid19
Subject code	610
Language	English
Publishing date	2020-06-01T00:00:00Z
Publisher	Universitas Gadjah Mada
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Clinical cardiac manifestations in patients with coronavirus disease 2019 (COVID-19)

Herman, Hafizha / Gharini, Putrika PR / Kris Dinarti, Lucia

Journal of the Medical Sciences (Berkala ilmu Kedokteran); Vol 52, No; 2356-3931 ; 0126-1312

2020 Volume 3, Issue : Special Issue: COVID-19

Abstract	The pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 2 million people worldwide with case fatality rates between 3-15%. The pathophysiology of this newly emerging disease in affecting cardiovascular system is poorly understood. This review aimed to understand from various retrospective studies and case reports that have been published and updated during the pandemic of COVID-19 related to the underlying mechanism and cardiovascular interaction with coronavirus. A literature search was done with Google search, PubMed, European Society of Cardiology (ESC) and Journal of American Medical Association (JAMA) network since the early days of COVID-19 pandemic. Clinical presentation may be asymptomatic or the severe cases will have acute respiratory distress syndrome (ARDS). Protein spikes of SARS-CoV-2 virus use the angiotensin-converting enzyme 2 (ACE2) as viral entry to host cells. Due to the upregulation of ACE2, people with any pre-existing cardiac diseases are more vulnerable to the infection and more likely to have a severe condition of COVID-19 infection with a higher risk of mortality. On the other hand, ACE2 has protective effects against myocardial inflammation and lung injuries. Several cases of COVID-19 infection may have cardiac manifestations as a chief complaint or acute cardiac injury as the complication. Recent case reports show that acute cardiac injury, myocarditis, cardiogenic shock, thromboembolism, and arrhythmias could be the complications of COVID-19 even without history or risk factors of cardiovascular disease. There are several hypotheses related to the mechanism of acute cardiac injury in COVID-19 patients, including damage through ACE2 receptors, hypoxia, cardiac microvascular damage, and inflammatory response.COVID-19 infection can cause many interactions in the cardiovascular system, whether the patients already had chronic heart disease or not. Considering the lack of evidence of the RAS inhibitor in COVID-19, the use of ACE inhibitor/ARB should be continued unless contraindicated and may be beneficial in patients with hypertension, heart failure and diabetes mellitus. Early recognition of cardiac manifestations from COVID-19 infections will be the key to prevent short and long term cardiac adverse events.
Keywords	ACE inhibitor ; acute cardiac injury ; cardiogenic shock ; coronavirus ; myocarditis ; covid19
Subject code	610
Language	English
Publishing date	2020-06-04
Publisher	Journal of the Medical Sciences (Berkala ilmu Kedokteran)
Publishing country	id
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article: Cardiac Manifestations of Coronavirus Disease 2019 (COVID-19): a Multicenter Cohort Study

J Korean Med Sci

Abstract: BACKGROUND: This study aimed to investigate the cardiac manifestations of coronavirus disease 2019 ... COVID-19). METHODS: From February to March 2020, we prospectively and retrospectively enrolled ... consecutive patients diagnosed with COVID-19. Patient's data such as the demographic characteristics, symptoms ...

Abstract	BACKGROUND: This study aimed to investigate the cardiac manifestations of coronavirus disease 2019 (COVID-19). METHODS: From February to March 2020, we prospectively and retrospectively enrolled consecutive patients diagnosed with COVID-19. Patient's data such as the demographic characteristics, symptoms, vital signs, laboratory and radiologic findings, electrocardiographic, and echocardiographic data, including the global longitudinal strain (GLS) of both ventricles, were obtained. RESULTS: Forty patients (median age, 58 years; 50% men) were enrolled in the initial analysis. Patients were classified into severe and nonsevere groups based on the current guidelines. The 13 patients in the severe group were significantly older, had a greater prevalence of bilateral pneumonia and leukocytosis, and higher aspartate transaminase levels than patients in the nonsevere group. Patients in the severe group had a slightly lower left ventricular ejection fraction (LVEF) than those in the nonsevere group (median [interquartile range], 61.0% [58.5%, 62.3%] vs. 66.7% [60.6%, 69.8%], P = 0.015). In a subgroup of 34 patients in whom GLS could be analyzed, patients in the severe group had a significantly impaired left ventricular GLS (LVGLS) than those in the nonsevere group (-18.1% [-18.8%, -17.1%] vs. -21.7% [-22.9%, -19.9%], P = 0.001). There were no significant differences in total wall (RVGLStotal, -19.3% [-23.9%, -18.4%] vs. -24.3% [-26.0%, -22.6%], P = 0.060) and free wall (RVGLSfw, -22.7% [-27.2%, -18.6%] vs. -28.8% [-30.4%, -24.1%], P = 0.066) right ventricle GLS (RVGLS). CONCLUSION: Patients with severe COVID-19 had lower LVEF and LVGLS. RVGLS was not different between patients with severe and nonsevere COVID-19.
Keywords	covid19
Publisher	WHO
Document type	Article
Note	WHO #Covidence: #881335
Database	COVID19

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾

Article: The Spectrum of Cardiac Manifestations in Coronavirus Disease 2019 (COVID-19) - a Systematic Echocardiographic Study

Szekely, Yishay / Lichter, Yael / Taieb, Philippe / Banai, Ariel / Hochstadt, Aviram / Merdler, Ilan / Gal Oz, Amir / Rothschild, Ehud / Baruch, Guy / Peri, Yogev / Arbel, Yaron / Topilsky, Yan

Circulation

Abstract: Background: Information regarding the cardiac manifestations of COVID-19 is scarce. We performed ... a systematic and comprehensive echocardiographic evaluation of consecutive patients hospitalized with COVID-19 ... infection. Methods: 100 consecutive patients diagnosed with COVID-19 infection underwent complete ...

Abstract	Background: Information regarding the cardiac manifestations of COVID-19 is scarce. We performed a systematic and comprehensive echocardiographic evaluation of consecutive patients hospitalized with COVID-19 infection. Methods: 100 consecutive patients diagnosed with COVID-19 infection underwent complete echocardiographic evaluation within 24 hours of admission and were compared to reference values. Echocardiographic studies included left ventricular (LV) systolic and diastolic function, valve hemodynamics and right ventricular (RV) assessment, as well as lung ultrasound. A second exam was performed in case of clinical deterioration. Results: Thirty two patients (32%) had a normal echocardiogram at baseline. The most common cardiac pathology was RV dilatation and dysfunction (observed in 39% of patients), followed by LV diastolic dysfunction (16%) and LV systolic dysfunction (10%). Patients with elevated troponin (20%) or worse clinical condition did not demonstrate any significant difference in LV systolic function compared to patients with normal troponin or better clinical condition, but had worse RV function. Clinical deterioration occurred in 20% of patients. In these patients, the most common echocardiographic abnormality at follow-up was RV function deterioration (12 patients), followed by LV systolic and diastolic deterioration (in 5 patients). Femoral vein thrombosis (DVT) was diagnosed in 5 of 12 patients with RV failure. Conclusions:In COVID-19 infection, LV systolic function is preserved in the majority of patients, but LV diastolic and RV function are impaired. Elevated troponin and poorer clinical grade are associated with worse RV function. In patients presenting with clinical deterioration at follow-up, acute RV dysfunction, with or without DVT, is more common, but acute LV systolic dysfunction was noted in ≈20%.
Keywords	covid19
Publisher	WHO
Document type	Article
Note	WHO #Covidence: #32469253
Database	COVID19

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾

Article ; Online: Cardiac damage and tropism of severe acute respiratory syndrome coronavirus 2.

Tangos, Melina / Jarkas, Muhammad / Akin, Ibrahim / El-Battrawy, Ibrahim / Hamdani, Nazha

Current opinion in microbiology

2024 Volume 78, Page(s) 102437

Abstract: ... of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection worldwide, of which 6.97 million resulted in death. Virus ... and future prevention. In this review, we highlight cardiac manifestations that might arise ...

Abstract	Until now, the World Health Organization registered over 771 million cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection worldwide, of which 6.97 million resulted in death. Virus-related cardiovascular events and pre-existing heart problems have been identified as major contributing factors to global infection-related morbidity and mortality, emphasizing the necessity for risk assessment and future prevention. In this review, we highlight cardiac manifestations that might arise from an infection with SARS-CoV-2 and provide an overview of known comorbidities that worsen the outcome. Additionally, we aim to summarize the therapeutic strategies proposed to reverse virus-associated myocardial damage, which will be further highlighted in this review, with an outlook to successful recovery and prevention.
MeSH term(s)	Humans ; SARS-CoV-2 ; COVID-19 ; Tropism
Language	English
Publishing date	2024-02-23
Publishing country	England
Document type	Journal Article ; Review
ZDB-ID	1418474-6
ISSN	1879-0364 ; 1369-5274
ISSN (online)	1879-0364
ISSN	1369-5274
DOI	10.1016/j.mib.2024.102437
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 5514: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MG 51: Show issues

Order via subito

Details ▾

Article ; Online: NT-proBNP cardiac value in COVID-19: a focus on the paediatric population.

Sleem, Bshara / El Rassi, Christophe / Zareef, Rana / Bitar, Fadi / Arabi, Mariam

Cardiology in the young

2024 , Page(s) 1–10

Abstract: ... Coronavirus 2 virus and the subsequent COVID-19 pandemic, diagnosis of heart implications began to pose ... and COVID-19 outcomes such as high severity and fatality. In the paediatric population ... proBNP when compared to non-syndromic cohorts. Thus, more large-scale studies on existing COVID-19 data ...

Abstract	NT-proBNP is a peptide related to brain natriuretic peptide, a cardiac biomarker and a member of the natriuretic family of peptides. NT-proBNP has demonstrated its clinical utility in the assessment of a wide spectrum of cardiac manifestations. It is also considered a more precise diagnostic and prognostic cardiac biomarker than brain natriuretic peptide. With the appearance of the Severe Acute Respiratory Syndrome Coronavirus 2 virus and the subsequent COVID-19 pandemic, diagnosis of heart implications began to pose an increasing struggle for the physician. Echocardiography is considered a central means of evaluating cardiac disorders like heart failure, and it is considered a reliable method. However, other diagnostic methods are currently being explored, one of which involves the assessment of NT-proBNP levels. In the literature that involves the adult population, significant positive correlations were drawn between the levels of NT-proBNP and COVID-19 outcomes such as high severity and fatality. In the paediatric population, however, the literature is scarce, and most of the investigations assess NT-proBNP in the context of Multiple Inflammatory Syndrome in Children, where studies have shown that cohorts with this syndrome had elevated levels of NT-proBNP when compared to non-syndromic cohorts. Thus, more large-scale studies on existing COVID-19 data should be carried out in the paediatric population to further understand the prognostic and diagnostic roles of NT-proBNP.
Language	English
Publishing date	2024-03-26
Publishing country	England
Document type	Journal Article ; Review
ZDB-ID	1078466-4
ISSN	1467-1107 ; 1047-9511
ISSN (online)	1467-1107
ISSN	1047-9511
DOI	10.1017/S1047951124000283
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 4050: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

To top

Kategorien

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Kategorien

Inter-library loan at ZB MED

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito